Heart Attack
Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
Published in Physician Business Week, September 25th, 2007
The study published in the Sept. 12 issue of the Journal of the American Medical Association reports that use of pioglitazone (Actos(TM)) is associated with a significantly lower risk of death, myocardial infarction, or stroke among a diverse population of diabetic patients.
In a meta-analysis of 19 trials comprising 16,390 patients, researchers found that 4.4% (375) of the 8,554 patients prescribed pioglitazone...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Business Week
More Articles from Physician Business Week
- MedeFinance, Inc.
Wise Regional Health System Chooses MedeFinance - nTelagent Inc.
nTelagent Self-Pay Management Solution Endorsed by Mississippi Hospital Association for Help with up-Front Cash Flow, Receivables and Overall Profitability - Premier Inc.
Hospital Savings top $19 million in Premier's 6th Annual Collaborative Breakthrough Series - Wellness
Mercy Medical Center-Sioux City Engages Aegis for New Employer-Directed Healthcare Initiative - Addiction Medicine
Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults - Adverse Drug Reactions
Investigators at University of Ottawa, Department of Medicine zero in on adverse drug reactions - More from this issue of Physician Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
